Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Laboratoires Delbert
Deal Size : Undisclosed
Deal Type : Acquisition
Details : With the acquisition of Teralithe 250mg, divisible tablet and Teralithe LP 400mg, prolonged-release tablet (lithium carbonate), by Laboratoires DELBERT reinforces the strategy to ensure safe and continuous availability of Medications to patients and rein...
Product Name : Teralithe
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Undisclosed
April 25, 2022
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Laboratoires Delbert
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 06, 2024
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lithium Versus Lamotrigine in Bipolar Disorder, Type II
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 28, 2023
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Electroconvulsive Therapy and Concomitant Lithium in Depressive Disorder: A Pilot Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 28, 2023
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase IV
Sponsor : Mental Health Center, Glostrup | Mental Health Center North Zealand | Mental Health Department Odense, University Clinic | Psychiatric Center Copenhagen, Rigshospitalet
Deal Size : Inapplicable
Deal Type : Inapplicable
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 22, 2023
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Sponsor : Mental Health Center, Glostrup | Mental Health Center North Zealand | Mental Health Department Odense, University Clinic | Psychiatric Center Copenhagen, Rigshospitalet
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : Canadian Institutes of Health Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 21, 2016
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : Canadian Institutes of Health Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase IV
Sponsor : CellPrint Biotechnology | National Alliance for Research on Schizophrenia and Depression
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 21, 2016
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Sponsor : CellPrint Biotechnology | National Alliance for Research on Schizophrenia and Depression
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Algorithm Guided Treatment Strategies for Bipolar Depression
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 10, 2013
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lithium Augmentation for Hyperarousal Symptoms of Post Traumatic Stress Disorder: Pilot Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 21, 2012
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 29, 2012
Lead Product(s) : Lithium Carbonate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable